clinical trial · NCT06973031
A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Kardium Inc.·N/A·recruiting·n = 115
Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial FibrillationGlobe Pulsed Field System
brief summary
The study will evaluate the safety and 12-month effectiveness of the Pulmonary Vein Isolation plus Box Isolation of Fibrotic Areas (BIFA) ablation strategy with the Globe Pulsed Field System (Globe PF System) for the treatment of atrial fibrillation.
started
Jun 10, 2025
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Jun 16, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol